Literature DB >> 17848702

Body MR imaging at 3.0 T: understanding the opportunities and challenges.

Mara M Barth1, Martin P Smith, Ivan Pedrosa, Robert E Lenkinski, Neil M Rofsky.   

Abstract

The development of high-field-strength magnetic resonance (MR) imaging systems has been driven in part by expected improvements in signal-to-noise ratio, contrast-to-noise ratio, spatial-temporal resolution trade-off, and spectral resolution. However, the transition from 1.5- to 3.0-T MR imaging is not straightforward. Compared with body imaging at lower field strength, body imaging at 3.0 T results in altered relaxation times, augmented and new artifacts, changes in chemical shift effects, and a dramatic increase in power deposition, all of which must be accounted for when developing imaging protocols. Inhomogeneities in the static magnetic field and the radiofrequency field at 3.0 T necessitate alterations in the design of coils and other hardware and new approaches to pulse sequence design. Techniques to reduce total body heating are demanded by the physics governing the specific absorption rate. Furthermore, the siting and maintenance of 3.0-T MR imaging systems are complicated by additional safety hazards unique to high-field-strength magnets. These aspects of 3.0-T body imaging represent current challenges and opportunities for radiology practice. (c) RSNA, 2007.

Mesh:

Year:  2007        PMID: 17848702     DOI: 10.1148/rg.275065204

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  33 in total

1.  Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.

Authors:  J Hwang; S H Kim; M W Lee; J Y Lee
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.

Authors:  X Yao; M Zeng; H Wang; S Fei; S Rao; Y Ji
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

3.  [MRI for therapy control in patients with aortic isthmus stenosis].

Authors:  B J Wintersperger; D Theisen; M F Reiser
Journal:  Radiologe       Date:  2011-01       Impact factor: 0.635

4.  Renal imaging at 7 Tesla: preliminary results.

Authors:  Lale Umutlu; Stephan Orzada; Sonja Kinner; Stefan Maderwald; Irina Brote; Andreas K Bitz; Oliver Kraff; Susanne C Ladd; Gerald Antoch; Mark E Ladd; Harald H Quick; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2010-09-25       Impact factor: 5.315

5.  Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

Authors:  Huaijun Wang; Guy Marchal; Yicheng Ni
Journal:  World J Radiol       Date:  2011-01-28

6.  Newly developed surface coil for endoluminal MRI, depiction of pig gastric wall layers and vascular architecture in ex vivo study.

Authors:  Yoshinori Morita; Hiromu Kutsumi; Hayato Yoshinaka; Yuichiro Matsuoka; Kagayaki Kuroda; Masakazu Gotanda; Naomi Sekino; Etsuko Kumamoto; Masaru Yoshida; Hideto Inokuchi; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2009-03-17       Impact factor: 7.527

7.  Comparative analysis of fluorescent angiography, computed tomographic angiography and magnetic resonance angiography for planning autologous breast reconstruction.

Authors:  Michael P Chae; David J Hunter-Smith; Warren Matthew Rozen
Journal:  Gland Surg       Date:  2015-04

Review 8.  [New developments in MRI of the liver].

Authors:  N Bastati-Huber; H Prosch; S Baroud; S Magnaldi; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

9.  MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization.

Authors:  B Sacconi; R Argirò; Daniele Diacinti; A Iannarelli; M Bezzi; C Cipriani; D Pisani; V Cipolla; C De Felice; S Minisola; C Catalano
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

10.  Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Authors:  Daniel A Feeney; Leslie C Sharkey; Susan M Steward; Katherine L Bahr; Michael S Henson; Daisuke Ito; Timothy D O'Brien; Carl R Jessen; Brian D Husbands; Antonella Borgatti; Jaime F Modiano
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.